Lung Cancer /

David Carbone, MD, PhD, FASCO; The Ohio State University Comprehensive Cancer Center; 5Live; #IASLC21

6:56

Lung Cancer

Lung Cancer Similar Videos

Similar Videos

Overview of actionable mutations in NSCLC_Marianne Davies DNP, ACNP, AOCNP, FAAN

8:02
Antibody-Drug Conjugates in Lung Cancer_Benjamin Levy, MD

50:57
Clinical experience with approved targeted therapies_Elizabeth Waxman, BSN, MSN, ANP-BC

12:29

ABOUT

Bio Ascend is an independent medical education company committed to supporting healthcare providers in their efforts to translate innovative science into clinical practice.

The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components, as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.

CONNECT

support@bioascend.com

(888) 476-9129

980 North Michigan Avenue, Suite 1400, Chicago, IL 60611